Monoclonal antibodies in cancer treatment. BioDrugs. 1999;12: 209-36.Alpaugh K, Von Mehern M: Monoclonal antibodies in cancer treatment. A Review of Recent Progress Biodrugs 12: 209-236, 1999.Alpaugh, K., Von Mehern, M. (1999) Monoclonal antibodies in cancer treatment. A Review of ...
Monoclonal Antibodies: Purification, Application in Conventional Methods and Cutting Edge Technology Nitesh Malhotra Aksh Chahal Jagriti Narang Biomedical Materials & Devices(2024) Review of cancer therapies for the perioperative physician Anahita Dabo-Trubelja ...
Monoclonal antibodies (mAbs) that regulate the immune response are now being clinically evaluated as anticancer agents. This Review discusses their progress to date and the possibilities for combining these antibodies with other cancer treatments. Increa
Research advances and promising clinical outcomes with immunotherapeutics has led to a resurgence of incorporating monoclonal antibodies in cancer treatment. Unconjugated, conjugated and multi-target constructs are emerging as a conventional form of therapy along with the classical trio of surgery, radiation...
Bispecific antibodies for cancer therapy: A review. Pharmacol Ther , 2018 , 185: 122 -134 Google Scholar [37] Peyrin-Biroulet L, Demarest S, Nirula A. Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies. Autoimmun Rev , 2019 , 18(2): 123 -128...
Monoclonal Antibody Therapy is a cancer treatment that utilizes antibodies to target tumor cells and stimulate the immune system for long-lasting responses. AI generated definition based on: Methods in Cell Biology, 2023 About this pageSet alert Also in subject areas: Agricultural and Biological Scien...
Few cancer therapies have attracted the level of interest given to monoclonal antibodies. These drugs, first approved for cancer treatment in the late 1990s, provide unprecedented target specificity. In so doing, they have begun to fulfill the concept pu
To discuss the scientific rationale for the use of monoclonal antibodies in cancer treatment and distinguish the unique characteristics of selected monoclonal antibodies. Published scientific papers, abstracts, review articles, and book chapters. The continued discovery of intrinsic antigens/epitopes specific...
However, administration of mAbs carries the risk of immune reactions such as acute anaphylaxis, serum sickness and the generation of antibodies. In addition, there are numerous adverse effects of mAbs that are related to their specific targets, including infections and cancer, autoimmune disease, and...
Of the spectrum of new agents in development for the treatment of MM, monoclonal antibodies (mAbs) have emerged as a potential strategy based on the range of antigens highly expressed on the surface of the malignant cell (Figure 1). In other cancers, mAb-based therapy is already established...